US Patent Number

10,301,320

Publication Date

5-28-2019

Abstract

Compounds and methods of modulating 15-PGDH activity, modulating tissue prostaglandin levels, treating disease, diseases disorders, or conditions in which it is desired to modulate 15-PGDH activity and/or prostaglandin levels include 15-PGDH inhibitors and 15-PGDH activators described herein.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US), Case Western Reserve University, Cleveland, OH (US), Board of Regents of the University of Texas System, Austin, TX (US)

Application Number

15/359,330

Filing Date

11/22/2016

Share

COinS